Docosahexaenoic acid is a substrate for ACAT1 and inhibits cholesteryl ester formation from oleic acid in MCF-10A cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 2-3, 2009, Pages 165-171

  Antalis, Caryl J ^a   Arnold, Tyler ^c   Lee, Bonggi ^b   Buhman, Kimberley K ^b   Siddiqui, Rafat A ^a,c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACAT1; Breast cancer; Docosahexaenoic acid; Oleic acid

Indexed keywords

ACYL COENZYME A; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ARTICLE; BREAST CANCER; BREAST CELL; CELL TYPE; CHOLESTEROL ESTERIFICATION; MICROSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYL-COA C-ACETYLTRANSFERASE; ACYL COENZYME A; BIOCATALYSIS; CELL LINE; CELL LINE, TUMOR; CHOLESTEROL ESTERS; CYTOPLASMIC GRANULES; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; FEMALE; GENE EXPRESSION; HUMANS; KINETICS; MICROSOMES; OLEIC ACID; TRIGLYCERIDES;

EID: 61849156329     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.01.001     Document Type: Article

References (31)

1. Chang T.Y., Chang C.C., and Cheng D. Acyl-coenzyme A: cholesterol acyltransferase. Annu. Rev. Biochem. 66 (1997) 613-638
2. Cases S., Novak S., Zheng Y.W., Myers H.M., Lear S.R., Sande E., Welch C.B., Lusis A.J., Spencer T.A., Krause B.R., Erickson S.K., and Farese Jr. R.V. ACAT-2, a second mammalian acyl-CoA: cholesterol acyltransferase. Its cloning, expression, and characterization. J Biol. Chem. 273 (1998) 26755-26764
3. Parini P., Davis M., Lada A.T., Erickson S.K., Wright T.L., Gustafsson U., Sahlin S., Einarsson C., Eriksson M., Angelin B., Tomoda H., Omura S., Willingham M.C., and Rudel L.L. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Circulation 110 (2004) 2017-2023
4. Brown M.S., Ho Y.K., and Goldstein J.L. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J Biol. Chem. 255 (1980) 9344-9352
5. Joyce C.W., Shelness G.S., Davis M.A., Lee R.G., Skinner K., Anderson R.A., and Rudel L.L. ACAT1 and 2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. Mol. Biol. Cell 11 (2000) 3675-3687
6. Rustan A.C., Nossen J.O., Osmundsen H., and Drevon C.A. Eicosapentaenoic acid inhibits cholesterol esterification in cultured parenchymal cells and isolated microsomes from rat liver. J. Biol. Chem. 263 (1988) 8126-8132
7. Pal S., and Davis P.J. Effects of different types of polyunsaturated fatty acids on cholesterol esterification in human fibroblasts. Biochem. Int. 25 (1991) 281-288
8. Davis P.J. n-3 and n-6 polyunsaturated fatty acids have different effects on acyl-CoA: cholesterol acyltransferase in J774 macrophages. Biochem. Cell Biol. 70 (1992) 1313-1318
9. Seo T., Oelkers P.M., Giattina M.R., Worgall T.S., Sturley S.L., and Deckelbaum R.J. Differential modulation of ACAT1 and 2 transcription and activity by long chain free fatty acids in cultured cells. Biochemistry 40 (2001) 4756-4762
10. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
11. Agren J.J., Julkunen A., and Penttila I. Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J. Lipid Res. 33 (1992) 1871-1876
12. Morrison W.R., and Smith L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res. 5 (1964) 600-608
13. Temel R.E., Gebre A.K., Parks J.S., and Rudel L.L. Compared with acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. J. Biol. Chem. 278 (2003) 47594-47601
14. Soule H.D., Maloney T.M., Wolman S.R., Peterson Jr. W.D., Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., and Brooks S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50 (1990) 6075-6086
15. Tosi M.R., and Tugnoli V. Cholesteryl esters in malignancy. Clin. Chim. Acta 359 (2005) 27-45
16. Schonberg S.A., Lundemo A.G., Fladvad T., Holmgren K., Bremseth H., Nilsen A., Gederaas O., Tvedt K.E., Egeberg K.W., and Krokan H.E. Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1. FEBS J. 273 (2006) 2749-2765
17. Batetta B., Pani A., Putzolu M., Sanna F., Bonatesta R., Piras S., Spano O., Mulas M.F., and Dessi S. Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines. Cell Prolif. 32 (1999) 49-61
18. Peiretti E., Dessi S., Mulas C., Abete C., Norfo C., Putzolu M., and Fossarello M. Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3450-3458
19. Li Y.C., Park M.J., Ye S.K., Kim C.W., and Kim Y.N. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am. J. Pathol. 168 (2006) 1107-1118 quiz 1404-1105
20. MacLean C.H., Newberry S.J., Mojica W.A., Khanna P., Issa A.M., Suttorp M.J., Lim Y.W., Traina S.B., Hilton L., Garland R., and Morton S.C. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295 (2006) 403-415
21. Barascu A., Besson P., Le Floch O., Bougnoux P., and Jourdan M.L. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int. J. Biochem. Cell Biol. 38 (2006) 196-208
22. Meuwese M.C., Franssen R., Stroes E.S., and Kastelein J.J. And then there were acyl coenzyme A:cholesterol acyl transferase inhibitors. Curr. Opin. Lipidol. 17 (2006) 426-430
23. Nissen S.E., Tuzcu E.M., Brewer H.B., Sipahi I., Nicholls S.J., Ganz P., Schoenhagen P., Waters D.D., Pepine C.J., Crowe T.D., Davidson M.H., Deanfield J.E., Wisniewski L.M., Hanyok J.J., and Kassalow L.M. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N. Engl. J. Med. 354 (2006) 1253-1263
24. Fazio S., Major A.S., Swift L.L., Gleaves L.A., Accad M., Linton M.F., and Farese Jr. R.V. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J. Clin. Invest. 107 (2001) 163-171
25. Harris W.S., Miller M., Tighe A.P., Davidson M.H., and Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197 (2008) 12-24
26. Hutter-Paier B., Huttunen H.J., Puglielli L., Eckman C.B., Kim D.Y., Hofmeister A., Moir R.D., Domnitz S.B., Frosch M.P., Windisch M., and Kovacs D.M. The ACAT inhibitor CP-113, 818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44 (2004) 227-238
27. Huttunen H.J., Greco C., and Kovacs D.M. Knockdown of ACAT-1 reduces amyloidogenic processing of APP. FEBS Lett. 581 (2007) 1688-1692
28. Calon F., and Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot. Essent. Fatty Acids 77 (2007) 287-293
29. De Caterina R., Liao J.K., and Libby P. Fatty acid modulation of endothelial activation. Am. J Clin. Nutr. 71 (2000) 213S-223S
30. Kuriki K., Nagaya T., Imaeda N., Tokudome Y., Fujiwara N., Sato J., Ikeda M., Maki S., and Tokudome S. Discrepancies in dietary intakes and plasma concentrations of fatty acids according to age among Japanese female dietitians. Eur. J. Clin. Nutr. 56 (2002) 524-531
31. Philibert A., Vanier C., Abdelouahab N., Chan H.M., and Mergler D. Fish intake and serum fatty acid profiles from freshwater fish. Am. J. Clin. Nutr. 84 (2006) 1299-1307